Adaptimmune
adaptimmune.comLocations
United States · United Kingdom · Oxton, York YO23 7AT, UK
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2008
Adaptimmune develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroys cancerous or infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was incorporated in 2007 and is based in Abingdon, United Kingdom.
Something looks off?Open jobs at Adaptimmune
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.